Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Closed at 11.76 looking great
What just another GREAT Quarter And they keep reducing the amount of shares out there with there buy back program
One of the best things you could do The shorts cant short if there are no shares out there
Is that a good thing?
They are buying back another 10 million dollars worth that will make 50 million dollars in buybacks in 2 years
Same thing i said. Idk whats going on.
Wtf is going on with this company man seriously?
In 1 month, -16.57% in losses. Something is up. Is it the CEO Thomas Sandgaard leadership? Please someone make it make sense!
Its an obvious scenario Trading at less than 2X revenue
On a rumor? Ha Ha
What's your source?
I keep hearing there going private!!! Have you gotten any info on this?
My first purchase was apx 20 years ago too. Quite a ride...
Good luck!
Unbelievable it is as cheap as it is right now.
I think i have owned some for 20 years or longer(don't quote me on time) I have bought as low as 10 cents Fun to watch Enjoy the ride
We will, IMHO
Great company, great future.
Buy now and smile later
How can we have these prices We should be like a 40 dollar stock as we speak
Is anyone hearing rumors that Zynex is going private?
Year end numbers come out after hours!! Good luck to everyone
Merry Christmas does anyone think we will get a rally towards the end of the year?
i Like the 13.85 but I believe we still go higher from here Anyone heard anything on the blood volume monitor?
It looks like we are going to break out from here (hello naked shorts) This might be fun
If the naked shorts have to cover there bets it could get good REAL SOON
The bottom line is finally growing. And I think the market likes the fact that there is blood monitor showing momentum.
Zynex Announces Additional Share Buyback Program
ENGLEWOOD, Colo., Nov. 1, 2022 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that its board of directors approved a program to buy back $10.0 million of the Company's common stock. The program will commence on November 1, 2022 and is scheduled to terminate on October 31, 2023 or when the $10.0 million buyback limit is reached.
Zynex
Zynex
"We are committed to driving long-term value for our shareholders and believe that the current strength of our balance sheet presents a strategic opportunity for a third buyback program," said Thomas Sandgaard, founder, and CEO of Zynex. "We've repurchased $20 million of our common stock thus far in 2022 and an additional $10 million share buyback reiterates our commitment to creating value. We believe our consistent performance and ability to maintain profitability is not reflected in Zynex's market valuation and are initiating this buyback program as an attractive opportunity to deploy capital and return value to our shareholders."
Under the share buyback program, buybacks may be made from time-to-time in open market and negotiated purchases, effective immediately through the next twelve months. These buybacks will be made in compliance with the SEC's Rule 10b-18, subject to market conditions, available liquidity, cash flow, applicable legal requirements, and other factors. The specific prices, numbers of shares, and timing of purchase transactions will be determined by the Company from time to time in its sole discretion. This program does not obligate the Company to acquire any particular amount of common stock, and the program may be suspended or discontinued at any time, including in the event the Company would be deemed to be making an acquisition of its own shares under Rule 13e-3 of the Securities Exchange Act of 1934, as amended.
The Company expects to finance the purchases with existing cash balances, which is not expected to have a material impact on capital levels.
Zynex, Inc. had approximately 41.6 million shares issued and 37.5 million shares outstanding as of November 1, 2022.
Maybe shorts are getting nervous !!!!
ZYXI 9.73
I'm guessing the recent strength may be due to expectations over the new blood volume monitor.
9.31 +7% Nice move
Yahoo shows forward of 20.66
Which is kind of ridiculous. That net income will go down.
I'm not sure what the forward PE is. How are you getting 8?
Zynex Rev up 18% Net Income up 19%
ENGLEWOOD, Colo., July 28, 2022 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported financial results for the second quarter ended June 30, 2022.
Second Quarter 2022 Highlights:
Revenue increased 18% year over year to $36.8 million
Net income increased 19% to $3.3 million; Diluted EPS of $0.08
Adjusted EBITDA increased 16% to $5.5 million
Completed initial $10 million share buyback and announced an additional program of $10 million
Recorded highest number of orders in Company history
Second Quarter 2022 Financial Results Summary:
For the second quarter, the Company reported net revenue of $36.8 million, an 18% increase over second quarter of 2021. Gross margins were 80% and net income was $3.3 million, a 19% increase from Q2 2021.
As of June 30, 2022, the Company had working capital of $51.8 million. Cash on hand was $26.9 million at the end of the second quarter.
President and CEO Commentary:
"In Q2, we posted another quarter of top line growth and increased profitability. Our reps are becoming highly efficient and revenue projections reflect our confidence in the sales force to produce exceptional results. The record orders we posted in second quarter will put us in a position to realize strong results in the second half of 2022," said Thomas Sandgaard, President and CEO. "Additionally, we completed an initial $10 million share buyback program and announced another $10 million program to signal our ability to drive shareholder value."
Third Quarter and Full Year 2022 Guidance:
Zynex is reaffirming its full year 2022 revenue estimates in the range of $150-$170 million and Adjusted EBITDA between $25-$35 million.
The estimated range for third quarter 2022 revenue is between $40-$43 million, an increase of approximately 20% from Q3 2021. Adjusted EBITDA for the third quarter 2022 is estimated to range between $7-$9 million.
Conference Call and Webcast Details:
Thursday, July 28, 2022 at 2:15 p.m. MT / 4:15 p.m. ET
To register and participate in the webcast, interested parties should click on the following link or dial in approximately 10-15 minutes prior to the webcast: https://app.webinar.net/mV4arKMJQLl
US Participant Dial In (TOLL FREE): 1-844-825-9790
International Participant Dial In: 1-412-317-5170
Canada Participant Dial In (TOLL FREE): 1-855-669-9657
Whats the forward P/E like 8?
ZYXI 6.92 (-21.98%) Well, that was short-lived. Maybe it was the buyback
Where do you hear that? I haven't heard that.
ZYXI (9.00 +18%) is having a good day today
ZYXI (9.00 +18%) is having a good day today
Im sending myself a note $8.10 is a nice close Friday
Looks like we are going higher from here What does everyone else think?
things to seem to be going well!!!! Going private?
What would happen to us >If they go private?
Anyone ever hear anything on company going private? I keep hearing some noise about it.?
My gut feeling for Zynex is that there is good news from this point onward. This company is expanding. The stock market in general is bullish, otherwise why is Warren Buffett on a buying spree. I think things for Zynex are good from here.
10 million dollar buyback This is looking great
Is anyone hearing rumors that Zynex is going private?
Twitter is anyone on that?
Friends tell me there talking about Zynex going Private
How bad would that hurt the shorts?
And what would be the price if that happened? My guess would be 25 bucks
Anyone seen any info on ZYNEX going private? I had a friend of mine ask me about it!!!
Simply Wall Street had a nice article today I found it on Yahoo Finance